790 related articles for article (PubMed ID: 17668211)
1. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
[TBL] [Abstract][Full Text] [Related]
2. Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
Yuvaraj S; Premkumar VG; Shanthi P; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Breast Cancer Res Treat; 2009 Mar; 114(2):377-84. PubMed ID: 18427979
[TBL] [Abstract][Full Text] [Related]
3. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
4. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
Perumal SS; Shanthi P; Sachdanandam P
Chem Biol Interact; 2005 Feb; 152(1):49-58. PubMed ID: 15766922
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy.
Premkumar VG; Yuvaraj S; Sathish S; Shanthi P; Sachdanandam P
Vascul Pharmacol; 2008; 48(4-6):191-201. PubMed ID: 18407793
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.
Premkumar VG; Yuvaraj S; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Basic Clin Pharmacol Toxicol; 2007 Jun; 100(6):387-91. PubMed ID: 17516992
[TBL] [Abstract][Full Text] [Related]
7. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy.
Premkumar VG; Yuvaraj S; Shanthi P; Sachdanandam P
Br J Nutr; 2008 Dec; 100(6):1179-82. PubMed ID: 18377693
[TBL] [Abstract][Full Text] [Related]
8. Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice.
Parvez S; Tabassum H; Rehman H; Banerjee BD; Athar M; Raisuddin S
Toxicology; 2006 Aug; 225(2-3):109-18. PubMed ID: 16797820
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages.
Kasapović J; Pejić S; Todorović A; Stojiljković V; Pajović SB
Cell Biochem Funct; 2008 Aug; 26(6):723-30. PubMed ID: 18636415
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitamin C on lipidperoxidation and antioxidant status in tamoxifen-treated breast cancer patients.
Muralikrishnan G; Amanullah S; Basha MI; Boopalan S; Vijayakumar S; Shakeel F
Chemotherapy; 2010; 56(4):298-302. PubMed ID: 20714147
[TBL] [Abstract][Full Text] [Related]
11. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
12. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer.
Yeh CC; Hou MF; Tsai SM; Lin SK; Hsiao JK; Huang JC; Wang LH; Wu SH; Hou LA; Ma H; Tsai LY
Clin Chim Acta; 2005 Nov; 361(1-2):104-11. PubMed ID: 16009358
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice.
Tabassum H; Parvez S; Rehman H; Dev Banerjee B; Siemen D; Raisuddin S
Hum Exp Toxicol; 2007 Jun; 26(6):509-18. PubMed ID: 17698946
[TBL] [Abstract][Full Text] [Related]
14. Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia.
Ahmad R; Tripathi AK; Tripathi P; Singh R; Singh S; Singh RK
Singapore Med J; 2010 Feb; 51(2):110-5. PubMed ID: 20358148
[TBL] [Abstract][Full Text] [Related]
15. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
Ilanchezhian S; Thangaraju M; Sachdanandam P
Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin E on tamoxifen-treated breast cancer cells.
Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O
J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310
[TBL] [Abstract][Full Text] [Related]
19. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.
Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C
Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation.
Elango N; Samuel S; Chinnakkannu P
Clin Chim Acta; 2006 Nov; 373(1-2):92-8. PubMed ID: 16831410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
